US drug companies and the NHS
Podcast |
Business Daily
Publisher |
BBC
Media Type |
audio
Categories Via RSS |
Business
Publication Date |
Dec 09, 2019
Episode Duration |
00:18:03
Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the BBC's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University. (Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review